IGF-I 3′ Untranslated Region: Strain-Specific Polymorphisms and Motifs Regulating IGF-I in Osteoblasts

被引:19
|
作者
Smith, Spenser S. [1 ]
Kessler, Catherine B. [1 ]
Shenoy, Vikram [1 ]
Rosen, Clifford J. [2 ]
Delany, Anne M. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA
[2] Maine Med Ctr, Res Inst, Ctr Translat Res, Scarborough, ME 04074 USA
基金
美国国家卫生研究院;
关键词
GROWTH-FACTOR-I; RNA RECOGNITION; GENE-EXPRESSION; BONE; CANCER; MIR-29; ASSOCIATION; REPRESSION; BINDING; MICE;
D O I
10.1210/en.2012-1476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reduced IGF-I is associated with low bone mass in humans and mice. C3H/He/J (C3H) mice have higher skeletal IGF-I and greater bone mass than C57BL/6J (B6). We hypothesized that strain-related genotypic differences in Igf1 affected skeletal function. The Igf1 coding region is nonpolymorphic, but its 3' untranslated region (UTR) is polymorphic between C3H and B6. Luciferase-Igf1 3' UTR reporter constructs showed that these polymorphic regions did not affect UTR function. IGF-I splice variants give rise to a common mature IGF-I peptide, but different E peptides. We identified two splice products, exon 4 + 6 (Ea) and exon 4 + 5 + 6 (Eb, mechano-growth factor) and found that their abundance was unchanged during osteoblastic differentiation. The Igf1 3' UTR encoded by exon 6 contains alternative polyadenylation sites. Proximal site use produces a short 3' UTR of approximately 195 bases, whereas distal site usage results in an approximately 6300-base UTR. Although Igf1 mRNA levels did not change during osteoblastic differentiation, distal polyadenylation site usage was increased in B6 cells but not in C3H. The resulting long Igf1 RNA isoform is less stable and has decreased translation efficiency, which may be one mechanism contributing to decreased IGF-I in B6 vs. C3H mice. Although the long UTR contains a conserved [GU](18) repeat, which is a positive regulator of UTR activity, it is also targeted by negative regulators, miR-29 and miR-365. These microRNAs are increased in B6 and C3H cells during osteoblastic differentiation. Differential expression of the long Igf1 3' UTR isoform may be a possible mechanism for enhanced IGF-I regulation in B6 vs. C3H mice. (Endocrinology 154: 253-262, 2013)
引用
收藏
页码:253 / 262
页数:10
相关论文
共 50 条
  • [1] IGF-I and IGF-I Receptor Polymorphisms Among Elite Swimmers
    Ben-Zaken, Sigal
    Meckel, Yoav
    Dror, Nitzan
    Nemet, Dan
    Eliakim, Alon
    PEDIATRIC EXERCISE SCIENCE, 2014, 26 (04) : 470 - 476
  • [2] Global and Conditional Disruption of the Igf-I Gene in Osteoblasts and/or Chondrocytes Unveils Epiphyseal and Metaphyseal Bone-Specific Effects of IGF-I in Bone
    Xing, Weirong
    Kesavan, Chandrasekhar
    Pourteymoor, Sheila
    Mohan, Subburaman
    BIOLOGY-BASEL, 2023, 12 (09):
  • [3] Evidence for synergistic action of transthyretin and IGF-I over the IGF-I receptor
    Vieira, Marta
    Leal, Sonia S.
    Gomes, Claudio M.
    Saraiva, Maria Joao
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (04): : 797 - 804
  • [4] ROLE OF GI-I AND IGF-I IN THE REGULATION OF IGF-I, IGF-I RECEPTOR AND IGF BINDING-PROTEIN GENE-EXPRESSION IN THE RAT SPLEEN
    DOMENE, HM
    MEIDAN, R
    YAKAR, S
    SHENORR, Z
    CASSORLA, F
    ROBERTS, CT
    LEROITH, D
    REGULATORY PEPTIDES, 1994, 52 (03) : 215 - 226
  • [5] Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling
    Sivaramakrishnan, Manaswini
    Croll, Tristan I.
    Gupta, Rajesh
    Stupar, Dario
    Van Lonkhuyzen, Derek R.
    Upton, Zee
    Shooter, Gary K.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (12): : 3176 - 3185
  • [6] Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts
    McCarthy, Thomas L.
    Yun, Zhong
    Madri, Joseph A.
    Centrella, Michael
    GENE, 2014, 539 (01) : 141 - 151
  • [7] Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes - Role of insulin and IGF-I receptors
    Back, Karolina
    Brannmark, Cecilia
    Stralfors, Peter
    Arnqvist, Hans J.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 339 (1-2) : 130 - 135
  • [8] IGF-I: Panacea or Poison?
    LeRoith, Derek
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (10) : 4549 - 4551
  • [9] Association of IGF-I and the IGF-I/IGFBP-3 Ratio with Plasma Aldosterone Levels in the General Population
    Hannemann, A.
    Wallaschofski, H.
    Rettig, R.
    Voelzke, H.
    Samietz, S.
    Nauck, M.
    Bidlingmaier, M.
    Friedrich, N.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (03) : 228 - 233
  • [10] IGF-I and the aging mammalian brain
    Piriz, J.
    Muller, A.
    Trejo, J. L.
    Torres-Aleman, I.
    EXPERIMENTAL GERONTOLOGY, 2011, 46 (2-3) : 96 - 99